The Network State Podcast #31 - The Don't Die Network State | Bryan Johnson
19 snips
Jan 15, 2026 
Bryan Johnson, an entrepreneur and longevity investor behind the Blueprint project, dives into transformative ideas around health and longevity. He discusses the transition to large-effect gene therapies and the potential of visual changes in health to inspire belief in therapies. The pair explore regulatory challenges, self-experimentation ethics, and innovations like wearable brain monitoring for everyday tracking. They envision a future where intensive diagnostics and gene therapies converge to create a 'Don't Die Network State' aimed at enhancing human life.
AI Snips
Chapters
Books
Transcript
Episode notes
Regulatory Paradox On Risk And Self-Experimentation
- Current regulation permits risky consumer choices (fast food, extreme sports) but blocks experimental self-improvement.
- The paradox: people can harm themselves freely yet cannot access potentially beneficial, well-informed interventions.
Characterize Yourself Before Risky Therapies
- Sequence genomes and run inexpensive pharmacogenomic checks before risky therapies to identify likely responders and reduce harm.
- Use cheap tests and family data to tailor dosing and offset regulatory concerns.
Top Modalities For Big Effect Sizes
- Gene and cell therapies plus OSK (Yamanaka factors) sit atop the list of interventions likely to produce large effect sizes.
- These modalities promise more durable, high-impact changes than parabiosis or basic lifestyle tweaks.
